Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) stock is trading almost flat in the pre-market session after the news. The stock has been gaining momentum over the past 6-month with a gain of 26%.
Market Reaction
As of 7:45, AMPE stock is unchanged at $1.78 with more than 1.95K shares traded hands.
Major Trigger:
Ampio Pharmaceuticals to Present at the 2021 International Society for Pharmaceutical Engineers Annual Meeting and Expo
Key Highlights:
- today announced details on the Company’s poster presentation, “Pivoting From One to Multiple Production Platforms to Treat COVID,” being given at the 2021 International Society for Pharmaceutical Engineers (ISPE) Annual Meeting and Expo in Boston, Massachusetts from November 1st to 3rd, 2021.
- ISPE’s 2021 Annual Meeting and Expo will include an educational agenda focused on the latest innovative developments in supply chain, operations, facilities, equipment, information systems, product development, production systems, quality systems and regulatory guidance.
- Ampio’s presentation, entitled “Pivoting From One to Multiple Production Platforms to Treat COVID,” is scheduled for Tuesday November 2, 2021, from 10:30 am to 12:00 pm ET and will take place during the Agile Innovation in Lifesciences Development and Manufacturing session track.
- The presentation highlights Ampio’s innovative work which has significantly and rapidly expanded the capabilities of its wholly owned, automated drug manufacturing facility that was initially focused on producing 4 cc vials of its platform immunomodulatory drug Ampion™ for intra-articular injections into patients with osteoarthritis of the knee. In less than 4 months, the manufacturing facility was reprogrammed to manufacture Ampion products packaged to be clinically administered in doses more than ten times larger, either intravenously (IV) to, or inhaled by, patients suffering from acute respiratory distress due to COVID-19.
){kind=link}